Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

A Markov model to estimate Salmonella morbidity, mortality, illness duration, and cost.

Herrick RL, Buchberger SG, Clark RM, Kupferle M, Murray R, Succop P.

Health Econ. 2012 Oct;21(10):1169-82. doi: 10.1002/hec.1779. Epub 2011 Sep 2.

PMID:
21887809
2.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
3.

Cost of schizophrenia in England.

Mangalore R, Knapp M.

J Ment Health Policy Econ. 2007 Mar;10(1):23-41.

PMID:
17417045
4.

Epidemiology of hospital-treated Salmonella infection; data from a national cohort over a ten-year period.

Gil Prieto R, Alejandre CG, Meca AA, Barrera VH, de Miguel AG.

J Infect. 2009 Mar;58(3):175-81. doi: 10.1016/j.jinf.2009.01.002. Epub 2009 Feb 5.

PMID:
19195712
5.

Economic and health impacts associated with a Salmonella Typhimurium drinking water outbreak-Alamosa, CO, 2008.

Ailes E, Budge P, Shankar M, Collier S, Brinton W, Cronquist A, Chen M, Thornton A, Beach MJ, Brunkard JM.

PLoS One. 2013;8(3):e57439. doi: 10.1371/journal.pone.0057439. Epub 2013 Mar 18.

6.

Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).

Rothbard AB, Lee S, Blank MB.

J Ment Health Policy Econ. 2009 Dec;12(4):187-94.

PMID:
20195006
7.

Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999.

Kennedy M, Villar R, Vugia DJ, Rabatsky-Ehr T, Farley MM, Pass M, Smith K, Smith P, Cieslak PR, Imhoff B, Griffin PM; Emerging Infections Program FoodNet Working Group.

Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S142-8.

PMID:
15095183
8.

The global burden of nontyphoidal Salmonella gastroenteritis.

Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, Jones TF, Fazil A, Hoekstra RM; International Collaboration on Enteric Disease 'Burden of Illness' Studies.

Clin Infect Dis. 2010 Mar 15;50(6):882-9. doi: 10.1086/650733.

PMID:
20158401
9.

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

Standaert B, Parez N, Tehard B, Colin X, Detournay B.

Appl Health Econ Health Policy. 2008;6(4):199-216. doi: 10.2165/00148365-200806040-00003.

PMID:
19382820
10.

The economic burden of schizophrenia in Canada in 2004.

Goeree R, Farahati F, Burke N, Blackhouse G, O'Reilly D, Pyne J, Tarride JE.

Curr Med Res Opin. 2005 Dec;21(12):2017-28.

PMID:
16368053
11.

Epidemiology, disease spectrum and economic burden of non-typhoidal Salmonella infections in Taiwan, 2006-2008.

Chen PL, Li CY, Hsieh TH, Chang CM, Lee HC, Lee NY, Wu CJ, Lee CC, Shih HI, Ko WC.

Epidemiol Infect. 2012 Dec;140(12):2256-63. doi: 10.1017/S0950268812000088. Epub 2012 Feb 6.

PMID:
22309742
12.

Epidemiology of salmonellosis in California, 1990-1999: morbidity, mortality, and hospitalization costs.

Trevejo RT, Courtney JG, Starr M, Vugia DJ.

Am J Epidemiol. 2003 Jan 1;157(1):48-57.

PMID:
12505890
13.

Costs of illness: United States, 1980.

Parsons PE, Lichtenstein R, Berki SE, Murt HA, Lepkowski JM, Stehouwer SA, Landis JR.

Natl Med Care Util Expend Surv C. 1986 Apr;(3):1-90.

PMID:
10313412
14.

Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model.

El Saadany S, Coyle D, Giulivi A, Afzal M.

Eur J Health Econ. 2005 Jun;6(2):159-65.

PMID:
15761777
15.

Cardiovascular disease costs associated with uncontrolled hypertension.

Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, Arocho R.

Manag Care Interface. 2002 Nov;15(11):28-36.

PMID:
12449899
16.

Economic burden from health losses due to foodborne illness in the United States.

Scharff RL.

J Food Prot. 2012 Jan;75(1):123-31. doi: 10.4315/0362-028X.JFP-11-058.

PMID:
22221364
17.

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.

Lindgren P, Stenestrand U, Malmberg K, Jönsson B.

Clin Ther. 2005 Jan;27(1):100-10.

PMID:
15763611
18.

Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality.

Leigh JP, Markowitz SB, Fahs M, Shin C, Landrigan PJ.

Arch Intern Med. 1997 Jul 28;157(14):1557-68.

PMID:
9236557
19.

Modeling the lifetime costs of treating schizophrenia in Australia.

Langley-Hawthorne C.

Clin Ther. 1997 Nov-Dec;19(6):1470-95; discussion 1424-5.

PMID:
9444454
20.

New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada.

Bentkover JD, Stewart EJ, Ignaszewski A, Lepage S, Liu P, Cooper J.

Int J Cardiol. 2003 Mar;88(1):33-41.

PMID:
12659982

Supplemental Content

Support Center